SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that ...
Achieved Record Quarterly Revenue of $387 Million; Strong Year to Date Operating Cash Flow of $88 MillionSecured $745 Million of Automotive New Business Awards in the QuarterRevenue Mid-point Raised ...
Investing.com -- Giant Biogene has received a certificate from China’s National Medical Products Administration (NMPA) for its recombinant Type I collagen facial injectable with native human sequence, ...
Achieved Record Quarterly Revenue of $387 Million; Strong Year to Date Operating Cash Flow of $88 MillionSecured $745 Million of Automotive New Business Awards in the QuarterRevenue Mid-point Raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback